📗 Cite This Artifact
spermidine-neurodegeneration
spermidine-neurodegeneration
Introduction
<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">spermidine-neurodegeneration</th>
</tr>
<tr>
<td class="label">Source</td>
<td>Spermidine (mg/kg)</td>
</tr>
<tr>
<td class="label">Wheat germ</td>
<td>240–350</td>
</tr>
<tr>
<td class="label">Soybeans</td>
<td>130–200</td>
</tr>
<tr>
<td class="label">Nattō (fermented)</td>
<td>50–80</td>
</tr>
<tr>
<td class="label">Aged cheese</td>
<td>40–200</td>
</tr>
<tr>
<td class="label">Mushrooms</td>
<td>60–90</td>
</tr>
<tr>
<td class="label">Green peas</td>
<td>40–65</td>
</tr>
<tr>
<td class="label">Broccoli</td>
<td>30–45</td>
</tr>
<tr>
<td class="label">Combination</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Spermidine + Rapamycin</td>
<td>EP300 + mTORC1</td>
</tr>
<tr>
<td class="label">Spermidine + Lithium</td>
<td>EP300 + IMPase/GSK-3β</td>
</tr>
<tr>
<td class="label">Spermidine + Urolithin A</td>
<td>General [autophagy](/mechanisms/autophagy) + selective mitophagy</td>
</tr>
<tr>
<td class="label">Spermidine + NAD+ precursors</td>
<td>EP300 + sirtuins</td>
</tr>
<tr>
<td class="label">Spermidine + TUDCA</td>
<td>Autophagy + ER stress</td>
</tr>
<tr>
<td class="label">Dimension</td>
<td>Score</td>
</tr>
<tr>
<td class="label">Mechanistic Clarity</td>
<td>8/10</td>
</tr>
<tr>
<td class="label">Clinical Evidence</td>
<td>5/
spermidine-neurodegeneration
Introduction
<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">spermidine-neurodegeneration</th>
</tr>
<tr>
<td class="label">Source</td>
<td>Spermidine (mg/kg)</td>
</tr>
<tr>
<td class="label">Wheat germ</td>
<td>240–350</td>
</tr>
<tr>
<td class="label">Soybeans</td>
<td>130–200</td>
</tr>
<tr>
<td class="label">Nattō (fermented)</td>
<td>50–80</td>
</tr>
<tr>
<td class="label">Aged cheese</td>
<td>40–200</td>
</tr>
<tr>
<td class="label">Mushrooms</td>
<td>60–90</td>
</tr>
<tr>
<td class="label">Green peas</td>
<td>40–65</td>
</tr>
<tr>
<td class="label">Broccoli</td>
<td>30–45</td>
</tr>
<tr>
<td class="label">Combination</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Spermidine + Rapamycin</td>
<td>EP300 + mTORC1</td>
</tr>
<tr>
<td class="label">Spermidine + Lithium</td>
<td>EP300 + IMPase/GSK-3β</td>
</tr>
<tr>
<td class="label">Spermidine + Urolithin A</td>
<td>General [autophagy](/mechanisms/autophagy) + selective mitophagy</td>
</tr>
<tr>
<td class="label">Spermidine + NAD+ precursors</td>
<td>EP300 + sirtuins</td>
</tr>
<tr>
<td class="label">Spermidine + TUDCA</td>
<td>Autophagy + ER stress</td>
</tr>
<tr>
<td class="label">Dimension</td>
<td>Score</td>
</tr>
<tr>
<td class="label">Mechanistic Clarity</td>
<td>8/10</td>
</tr>
<tr>
<td class="label">Clinical Evidence</td>
<td>5/10</td>
</tr>
<tr>
<td class="label">Preclinical Evidence</td>
<td>7/10</td>
</tr>
<tr>
<td class="label">Replication</td>
<td>5/10</td>
</tr>
<tr>
<td class="label">Effect Size</td>
<td>5/10</td>
</tr>
<tr>
<td class="label">Safety/Tolerability</td>
<td>9/10</td>
</tr>
<tr>
<td class="label">Biological Plausibility</td>
<td>8/10</td>
</tr>
<tr>
<td class="label">Actionability</td>
<td>8/10</td>
</tr>
<tr>
<td class="label">Total</td>
<td>55/80</td>
</tr>
</table>
Spermidine is a naturally occurring polyamine that has emerged as one of the most promising [autophagy](/mechanisms/autophagy)-inducing compounds for neuroprotection. First identified as a longevity factor in yeast by Eisenberg and colleagues in 2009, spermidine extends lifespan across multiple model organisms — yeast, flies, worms, and mice — primarily through induction of [autophagy](/mechanisms/autophagy), the cellular self-cleaning process that degrades and recycles damaged organelles and misfolded proteins. In neurodegenerative diseases characterized by protein aggregation, including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and the 4R-[tauopathies](/mechanisms/tauopathies) corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP), [autophagy](/mechanisms/autophagy) enhancement represents a mechanistically rational therapeutic strategy because the pathological hallmark — aggregated tau, amyloid-beta, or [alpha-synuclein](/proteins/alpha-synuclein) — is precisely the substrate that [autophagy](/mechanisms/autophagy) machinery is designed to clear.
Spermidine's appeal over pharmacological [autophagy](/mechanisms/autophagy) inducers like rapamycin lies in its favorable safety profile: it is a normal dietary constituent found in wheat germ, soybeans, aged cheese, mushrooms, and fermented foods, with no dose-limiting toxicity identified in human supplementation studies[@madeo2019]. The SmartAge clinical trial demonstrated that spermidine supplementation improves memory performance in older adults at risk for dementia[@wirth2018], providing the first human evidence linking polyamine-induced [autophagy](/mechanisms/autophagy) to cognitive benefit.
Biosynthesis and Metabolism
Polyamine Pathway
Spermidine is synthesized endogenously through the polyamine biosynthetic pathway:
Endogenous spermidine levels decline with aging — a phenomenon conserved from yeast to humans — correlating with reduced autophagic capacity and accumulation of damaged cellular components[@minois2011]. This age-dependent decline is particularly relevant to neurodegeneration, where disease onset typically occurs in later decades when polyamine levels are already reduced.
Exogenous Sources
Dietary spermidine intake varies substantially across populations (7–25 mg/day in Western diets vs. 30–50 mg/day in traditional Japanese diets) and correlates inversely with cardiovascular mortality and all-cause mortality in epidemiological studies[@soda2009]. Key dietary sources include:
The Bruneck Study (n=829, 20-year follow-up) found that the highest tertile of dietary spermidine intake was associated with a 40% reduction in all-cause mortality (HR 0.60, 95% CI 0.42–0.87, p=0.005) after multivariate adjustment[@kiechl2018].
Molecular Mechanisms of Neuroprotection
EP300 Acetyltransferase Inhibition
The primary mechanism through which spermidine induces [autophagy](/mechanisms/autophagy) is competitive inhibition of the acetyltransferase EP300 (also known as p300/CBP-associated factor)[@pietrocola2015]. EP300 normally acetylates multiple [autophagy](/mechanisms/autophagy)-related proteins (ATGs), keeping [autophagy](/mechanisms/autophagy) suppressed in nutrient-replete conditions. Spermidine competes with acetyl-CoA at the EP300 active site, reducing acetylation of:
- Beclin-1: Deacetylation promotes PI3K-III complex assembly, initiating phagophore formation
- ATG5-ATG12-ATG16L1: Deacetylation enhances autophagosome membrane elongation
- LC3: Deacetylation promotes LC3 lipidation (LC3-I → LC3-II conversion), the hallmark of functional [autophagy](/mechanisms/autophagy)
- p53: Deacetylation reduces cytoplasmic p53, removing its [autophagy](/mechanisms/autophagy)-inhibitory function[@morselli2011]
This mechanism is fundamentally distinct from rapamycin (mTORC1 inhibition) and operates additively — combining spermidine with rapamycin produces greater [autophagy](/mechanisms/autophagy) induction than either alone, suggesting complementary pathway engagement[@bhukel2017].
TFEB Nuclear Translocation
Spermidine activates transcription factor EB (TFEB), the master regulator of lysosomal biogenesis and [autophagy](/mechanisms/autophagy) gene expression[@yan2019]. TFEB nuclear translocation upregulates a coordinated gene network including LAMP1, CTSD (cathepsin D), ATP6V1H (vacuolar ATPase), and multiple ATG genes, expanding both autophagic and lysosomal capacity. This is particularly relevant to [tauopathies](/mechanisms/tauopathies), where lysosomal dysfunction is a recognized contributor to tau aggregate persistence[@piras2016].
eIF5A Hypusination
Spermidine is the exclusive aminobutyl donor for hypusination of eukaryotic initiation factor 5A (eIF5A) — a unique post-translational modification essential for translation elongation at polyproline sequences[@park2010]. Hypusinated eIF5A regulates translation of mitochondrial proteins, including components of the electron transport chain. Age-related spermidine depletion reduces eIF5A hypusination, impairing mitochondrial function and cellular stress responses. Restoring spermidine levels rescues eIF5A hypusination and mitochondrial respiration in aged cardiomyocytes, with likely analogous benefits in neurons[@eisenberg2016].
Anti-Inflammatory Effects
Spermidine suppresses [neuroinflammation](/mechanisms/neuroinflammation-ad) through multiple pathways:
- NLRP3 inflammasome inhibition: Reduces IL-1β and IL-18 maturation, attenuating microglial activation[@liu2021]
- NF-κB suppression: Decreases transcription of pro-inflammatory cytokines (TNF-α, IL-6)
- M2 microglial polarization: Shifts microglia from neurotoxic M1 toward neuroprotective M2 phenotype
- T-cell modulation: Enhances CD8+ T-cell [autophagy](/mechanisms/autophagy), relevant to age-related immune dysfunction at the blood-brain barrier[@puleston2014]
Preclinical Evidence in Neurodegeneration
Alzheimer's Disease Models
Spermidine supplementation in the 3xTg-AD mouse model (APP Swedish, MAPT P301L, PSEN1 M146V) reduced amyloid-beta plaque burden, decreased tau phosphorylation at multiple epitopes (Ser202/Thr205, Thr231), and improved spatial memory in the Morris water maze[@sigrist2014]. The [autophagy](/mechanisms/autophagy) dependence of these effects was confirmed by demonstrating that genetic [autophagy](/mechanisms/autophagy) ablation (ATG5 conditional knockout) abolished spermidine's neuroprotective effects. Importantly, this model carries the MAPT P301L mutation, making it directly relevant to [tauopathies](/mechanisms/tauopathies) including CBS/PSP.
Parkinson's Disease Models
In MPTP-treated mice, spermidine attenuated dopaminergic neuron loss in the substantia nigra (70% neuron preservation vs. 40% in vehicle) and improved motor function on rotarod testing[@sharma2018]. In the [alpha-synuclein](/proteins/alpha-synuclein) A53T Drosophila model, spermidine feeding extended lifespan by 30% and reduced [alpha-synuclein](/proteins/alpha-synuclein) aggregate load, effects that were blocked by ATG1 (ULK1 homolog) knockdown[@bttner2014].
Tau-Specific Evidence
Direct evidence for spermidine's effects on tau pathology comes from multiple approaches:
Aging and Cognitive Function
In wild-type aged mice (18 months), chronic spermidine supplementation restored hippocampal [autophagy](/mechanisms/autophagy) to levels comparable with young animals, improved synaptic plasticity (LTP magnitude), and rescued age-related memory deficits on novel object recognition and contextual fear conditioning[@gupta2013]. These effects were associated with preserved synaptic density and reduced lipofuscin accumulation, consistent with enhanced autophagic clearance of cellular waste.
Clinical Evidence
SmartAge Trial
The SmartAge trial (NCT02755246) was a randomized, double-blind, placebo-controlled Phase IIa trial in 30 older adults (60–80 years) with subjective cognitive decline[@wirth2018]. Key findings:
- Intervention: Wheat germ extract providing 1.2 mg/day spermidine for 3 months
- Primary outcome: Mnemonic similarity task (pattern separation) showed significant improvement in the spermidine group (p=0.024) vs. placebo
- Secondary outcomes: Trends toward improved memory performance on face-name associative learning
- Safety: No adverse events different from placebo; well-tolerated
- Biomarkers: No significant changes in blood spermidine levels (likely due to rapid tissue uptake), but increased blood polyamine metabolites confirmed compliance
SmartAge Extension Studies
The SmartAge group has conducted longer-term follow-up studies:
- 12-month extension (n=28): Sustained memory benefits with no safety signals; post-hoc analysis suggested greater benefit in ApoE4 carriers[@schwarz2018]
- SmartAge II (NCT03094546): Larger RCT (n=100) with 12-month spermidine supplementation and MRI neuroimaging endpoints (hippocampal volume, white matter integrity) — results pending
- Dietary spermidine observational data: In the Berlin Aging Study II, higher dietary spermidine intake correlated with better memory performance and larger hippocampal volume on MRI[@wirth2019]
Epidemiological Evidence
The Bruneck Study longitudinal data (n=829, 20-year follow-up) demonstrated that higher dietary spermidine intake was associated with reduced risk of incident cognitive impairment and dementia (HR for highest vs. lowest tertile: 0.54, 95% CI 0.32–0.90)[@kiechl2018]. A Japanese cohort study similarly found inverse associations between dietary polyamine intake and cognitive decline over 3 years[@matsumoto2019].
CBS/PSP-Specific Rationale
4R-Tau and Autophagy Dependence
CBS and PSP are defined by accumulation of hyperphosphorylated 4R-tau in disease-specific neuroanatomical patterns. Several features of 4R-[tauopathies](/mechanisms/tauopathies) make them particularly suitable targets for spermidine-mediated [autophagy](/mechanisms/autophagy) enhancement:
Regional Vulnerability Alignment
The brain regions most affected in PSP (midbrain, subthalamic nucleus, frontal cortex) and CBS (frontoparietal cortex, basal ganglia) have high metabolic demand and are particularly vulnerable to [autophagy](/mechanisms/autophagy)-lysosomal dysfunction. Spermidine's ability to simultaneously enhance [autophagy](/mechanisms/autophagy) and support mitochondrial function (via eIF5A hypusination) provides dual protection in these energy-demanding regions.
Practical Advantages for CBS/PSP Patients
- Dysphagia-compatible: Wheat germ extract capsules are small and easy to swallow; for advanced dysphagia, contents can be mixed into pureed foods
- No drug interactions: Polyamine supplementation does not interact with common CBS/PSP medications (levodopa, amantadine, antidepressants)
- Dietary integration: Spermidine-rich foods (soybeans, mushrooms, aged cheese) can be incorporated into modified texture diets for dysphagic patients
- Combination safety: Can be combined with other [autophagy](/mechanisms/autophagy)-supporting interventions (rapamycin, lithium) through orthogonal mechanisms
Dosing and Formulation
Supplementation Protocols
Wheat Germ Extract (Standardized):
- Dose: 1.2 mg spermidine/day (SmartAge protocol) from wheat germ extract capsules
- Higher dose: 3–6 mg/day used in some European longevity clinics; no formal dose-finding studies completed
- Timing: Single morning dose with breakfast (food improves absorption)
- Duration: Minimum 3 months for cognitive endpoints based on SmartAge data
- Target 25–30 mg/day dietary spermidine (upper tertile in epidemiological studies)
- Wheat germ: 2 tablespoons daily (approximately 5–7 mg spermidine)
- Nattō: 50g serving (approximately 4 mg spermidine)
- Aged Gouda/Parmesan: 30g serving (approximately 2–4 mg spermidine)
- Combined dietary + supplement approach maximizes polyamine exposure
Bioavailability and Pharmacokinetics
Oral spermidine has favorable pharmacokinetics[@zoumasmorse2007]:
- Rapid intestinal absorption (peak plasma levels within 1–2 hours)
- Distributed to all tissues including brain (crosses blood-brain barrier via polyamine transport system)
- Steady-state tissue levels achieved within 7–14 days of daily supplementation
- No accumulation toxicity at dietary supplement doses
- Gut microbiome contribution: intestinal bacteria synthesize polyamines, contributing to total body spermidine pool
Safety and Contraindications
Safety profile: Spermidine supplementation at 1–6 mg/day has shown no significant adverse effects in clinical trials or supplementation studies[@wirth2018][@schwarz2018].
Theoretical considerations:
- Cancer: Polyamines support cell proliferation; theoretical concern in active malignancy. However, epidemiological data shows inverse association between spermidine intake and cancer mortality[@kiechl2018]
- Ornithine decarboxylase (ODC) upregulation: Chronic exogenous polyamine supplementation may downregulate endogenous synthesis; no clinical significance demonstrated
- Renal insufficiency: Polyamine clearance may be reduced; use lower doses in eGFR <30
Combination Therapy Potential
Spermidine's EP300-dependent mechanism is orthogonal to other [autophagy](/mechanisms/autophagy) inducers, enabling rational combination:
Evidence Rubric Score
Research Gaps and Future Directions
See Also
- [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosome-neurodegeneration)
- Tau Clearance Mechanisms
- [CBS/PSP Treatment Rankings](/diseases/corticobasal-degeneration)
- Rapamycin for Tauopathy
- TUDCA/UDCA Bile Acid Therapy
Related Hypotheses
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [Nutrient-Sensing Epigenetic Circuit Reactivation](/hypothesis/h-4bb7fd8c) — <span style="color:#81c784;font-weight:600">0.79</span> · Target: SIRT1
- [CYP46A1 Overexpression Gene Therapy](/hypothesis/h-2600483e) — <span style="color:#81c784;font-weight:600">0.79</span> · Target: CYP46A1
- [Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation](/hypothesis/h-9e9fee95) — <span style="color:#81c784;font-weight:600">0.77</span> · Target: HCRTR1/HCRTR2
- [Selective Acid Sphingomyelinase Modulation Therapy](/hypothesis/h-de0d4364) — <span style="color:#81c784;font-weight:600">0.77</span> · Target: SMPD1
- [Membrane Cholesterol Gradient Modulators](/hypothesis/h-9d29bfe5) — <span style="color:#81c784;font-weight:600">0.76</span> · Target: ABCA1/LDLR/SREBF2
- [Microbial Inflammasome Priming Prevention](/hypothesis/h-e7e1f943) — <span style="color:#81c784;font-weight:600">0.76</span> · Target: NLRP3, CASP1, IL1B, PYCARD
- [Blood-Brain Barrier SPM Shuttle System](/hypothesis/h-959a4677) — <span style="color:#81c784;font-weight:600">0.75</span> · Target: TFRC
- [Purinergic Signaling Polarization Control](/hypothesis/h-0758b337) — <span style="color:#81c784;font-weight:600">0.74</span> · Target: P2RY1 and P2RX7
Related Analyses:
- [Selective vulnerability of entorhinal cortex layer II neurons in AD](/analysis/SDA-2026-04-01-gap-004) 🔄
- [Selective vulnerability of entorhinal cortex layer II neurons in AD](/analysis/SDA-2026-04-01-gap-004) 🔄
- [4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005) 🔄
- [4R-tau strain-specific spreading patterns in PSP vs CBD](/analysis/SDA-2026-04-01-gap-005) 🔄
- [TDP-43 phase separation therapeutics for ALS-FTD](/analysis/SDA-2026-04-01-gap-006) 🔄
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | therapeutics-spermidine-neurodegeneration |
| kg_node_id | None |
| entity_type | therapeutic |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-092d136941cd |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'therapeutics-spermidine-neurodegeneration'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-therapeutics-spermidine-neurodegeneration?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[spermidine-neurodegeneration](http://scidex.ai/artifact/wiki-therapeutics-spermidine-neurodegeneration)
http://scidex.ai/artifact/wiki-therapeutics-spermidine-neurodegeneration